CULLEN/FROST BANKERS, INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,328,214
+2.7%
22,857
+1.7%
0.04%
+5.1%
Q2 2023$2,267,549
+5.9%
22,471
-3.4%
0.04%0.0%
Q1 2023$2,140,288
-7.9%
23,264
-9.2%
0.04%
-11.4%
Q4 2022$2,324,791
+2.2%
25,626
-14.3%
0.04%
-15.4%
Q3 2022$2,274,000
-9.4%
29,911
+0.7%
0.05%
-7.1%
Q2 2022$2,510,000
-4.7%
29,691
-1.1%
0.06%
+9.8%
Q1 2022$2,634,000
-4.0%
30,015
-4.3%
0.05%
-1.9%
Q4 2021$2,744,000
+4.1%
31,370
-2.7%
0.05%
-1.9%
Q3 2021$2,636,000
-14.6%
32,229
-4.8%
0.05%
-14.5%
Q2 2021$3,088,000
+6.7%
33,848
-0.0%
0.06%
-1.6%
Q1 2021$2,894,000
-22.5%
33,853
-14.3%
0.06%
-26.7%
Q4 2020$3,732,000
+5.3%
39,524
-3.0%
0.09%
-2.3%
Q3 2020$3,544,000
+8.2%
40,757
+8.7%
0.09%
+2.3%
Q2 2020$3,274,000
+8.8%
37,480
+2.7%
0.09%
-18.1%
Q1 2020$3,009,000
-16.3%
36,504
-3.8%
0.10%
+7.1%
Q4 2019$3,594,000
-25.7%
37,954
-31.8%
0.10%
-31.5%
Q3 2019$4,835,000
-14.3%
55,639
-9.9%
0.14%
-17.8%
Q2 2019$5,640,000
-70.6%
61,772
-69.2%
0.17%
-70.5%
Q1 2019$19,208,000
+28.6%
200,495
+15.2%
0.59%
+6.3%
Q4 2018$14,938,000
-27.6%
174,086
-27.3%
0.56%
-14.0%
Q3 2018$20,634,000
+6.3%
239,487
-6.8%
0.64%
+7.1%
Q2 2018$19,412,000
-11.9%
256,982
-5.7%
0.60%
-7.1%
Q1 2018$22,031,000
+1.8%
272,491
+5.7%
0.65%
-5.4%
Q4 2017$21,644,000
-0.4%
257,786
+1.8%
0.68%
-3.8%
Q3 2017$21,741,000
+1.6%
253,245
-1.3%
0.71%
-1.1%
Q2 2017$21,408,000
+9.7%
256,478
-2.4%
0.72%
+8.1%
Q1 2017$19,519,000
-3.0%
262,803
-4.8%
0.67%
-3.8%
Q4 2016$20,119,000
-7.7%
276,198
+0.0%
0.69%
-11.6%
Q3 2016$21,803,000
-5.3%
276,129
-1.1%
0.78%
-8.3%
Q2 2016$23,035,000
+4.9%
279,185
-7.9%
0.85%
+3.9%
Q1 2016$21,964,000
-16.1%
303,193
-0.4%
0.82%
-16.9%
Q4 2015$26,189,000
-5.7%
304,373
+0.7%
0.99%
-10.3%
Q3 2015$27,782,000
-6.2%
302,247
+0.4%
1.10%
-0.1%
Q2 2015$29,613,000
+0.1%
301,128
+0.4%
1.10%
-0.4%
Q1 2015$29,576,000
+5.9%
299,931
-0.4%
1.11%
+3.2%
Q4 2014$27,917,000
+1.1%
301,286
+2.7%
1.07%
-4.0%
Q3 2014$27,625,000
+4.0%
293,480
+0.1%
1.12%
+4.4%
Q2 2014$26,550,000
+9.5%
293,272
+2.8%
1.07%
+2.7%
Q1 2014$24,251,000
+10.3%
285,234
+4.3%
1.04%
+7.0%
Q4 2013$21,980,000
+17.6%
273,451
+12.2%
0.98%
+6.4%
Q3 2013$18,696,000
+9.3%
243,723
+0.8%
0.92%
+2.1%
Q2 2013$17,103,000241,8780.90%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders